Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation

被引：0
|
作者：
J A Yared
N Hardy
Z Singh
S Hajj
A Z Badros
M Kocoglu
S Yanovich
E A Sausville
C Ujjani
K Ruehle
C Goecke
M Landau
A P Rapoport
机构：
[1] Greenebaum Cancer Center,Division of Hematology/Oncology
[2] University of Maryland,Department of Pathology
[3] University of Maryland,Department of Diagnostic Radiology and Nuclear Medicine
[4] University of Maryland,Division of Hematology/Oncology
[5] Lombardi Cancer Center,undefined
[6] Georgetown University,undefined
来源：
Bone Marrow Transplantation | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：850 / 852
页数：2
相关论文
共 50 条
  • [1] Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation
    Yared, J. A.
    Hardy, N.
    Singh, Z.
    Hajj, S.
    Badros, A. Z.
    Kocoglu, M.
    Yanovich, S.
    Sausville, E. A.
    Ujjani, C.
    Ruehle, K.
    Goecke, C.
    Landau, M.
    Rapoport, A. P.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 (06) : 850 - 852
  • [2] Nivolumab salvage therapy before and after allogeneic stem cell transplantation in relapsed/refractory hodgkin lymphoma
    Cheikh, J. E. I.
    Massoud, R.
    Abudalle, I.
    Haffar, B.
    Mahfouz, R.
    Kharfan-Dabaja, M. A.
    Jisr, T.
    Mougharbel, A.
    Ibrahim, A.
    Bazarbachi, A.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S29 - S30
  • [3] Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) after Treatment with Nivolumab for Relapsed/Refractory Hodgkin Lymphoma
    Armand, Philippe
    Zinzani, Pier Luigi
    Collins, Graham P.
    Cohen, Jonathon B.
    Halwani, Ahmad S.
    Carlo-Stella, Carmelo
    Millenson, Michael M.
    Provencio, Mariano
    Domenech, Eva Domingo
    Roth, Lisa Giulino
    Castagna, Luca
    Kato, Kazunobu
    McKiver, Mihaela Popa
    Sumbul, Anne
    Zhu, Lili
    Santoro, Armando
    [J]. BLOOD, 2016, 128 (22)
  • [4] Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation
    Angenendt, L.
    Schliemann, C.
    Lutz, M.
    Rebber, E.
    Schulze, A. B.
    Weckesser, M.
    Stegger, L.
    Schaefers, M.
    Groth, C.
    Kessler, T.
    Lenz, G.
    Stelljes, M.
    Berdel, W. E.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 443 - 445
  • [5] Nivolumab in a patient with refractory Hodgkin’s lymphoma after allogeneic stem cell transplantation
    L Angenendt
    C Schliemann
    M Lutz
    E Rebber
    A B Schulze
    M Weckesser
    L Stegger
    M Schäfers
    C Groth
    T Kessler
    G Lenz
    M Stelljes
    W E Berdel
    [J]. Bone Marrow Transplantation, 2016, 51 : 443 - 445
  • [6] Allogeneic stem cell transplantation in refractory Hodgkin's lymphoma after CR with Nivolumab
    Fellas, G.
    Kiehl, M.
    Hopfer, O.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 74 - 74
  • [7] Safety and efficacy of allogeneic stem cell transplantation after nivolumab therapy for patients with relapsed/refractory classical Hodgkin lymphoma
    Beynarovich, A.
    Lepik, K.
    Mikhailova, N.
    Kondakova, E.
    Zalyalov, Y.
    Moiseev, I.
    Afanasyev, B.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 22 - +
  • [8] Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
    Herbaux, Charles
    Gauthier, Jordan
    Brice, Pauline
    Drumez, Elodie
    Ysebaert, Loic
    Doyen, Helene
    Fornecker, Luc
    Bouabdallah, Krimo
    Manson, Guillaume
    Ghesquieres, Herve
    Tabrizi, Reza
    Hermet, Eric
    Lazarovici, Julien
    Thiebaut-Bertrand, Anne
    Chauchet, Adrien
    Demarquette, Helene
    Boyle, Eileen
    Houot, Roch
    Yakoub-Agha, Ibrahim
    Morschhauser, Franck
    [J]. BLOOD, 2017, 129 (18) : 2471 - 2478
  • [9] Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Castagna, Luca
    Carlo-Stella, Carmelo
    Mazza, Rita
    Santoro, Armando
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2015, 7
  • [10] Allogeneic stem cell transplantation for relapsed or refractory Hodgkin lymphoma: a better therapeutical perspective
    Greco, M. M.
    Carella, A. M.
    Merla, E.
    Cascavilla, N.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S288 - S289
12345